Abstract:Osteoclast lineage commitment and differentiation have been studied extensively, although the mechanism by which transcription factor(s) control osteoclast terminal differentiation, activation, and function remains unclear. CCAAT/enhancer-binding protein alpha (C/ebp alpha) has been reported to be a key regulator of osteoclast cell lineage commitment, yet C/ebp alpha's roles in osteoclast terminal differentiation, activation and function, and bone homeostasis, under physiological or pathological conditions, have not been studied because newborn C/ebp alpha-null mice die within several hours after birth. Furthermore, the function of C/ebp alpha in osteoclast terminal differentiation, activation, and function is largely unknown. Herein, we generated and analyzed an osteoclast-specific C/ebp alpha conditional knockout (CKO) mouse model via Ctsk-Cre mice and found that C/ebp alpha-deficient mice exhibited a severe osteopetrosis phenotype due to impaired osteoclast terminal differentiation, activation, and function, including mildly reduced osteoclast number, impaired osteoclast polarization, actin formation, and bone resorption, which demonstrated the novel function of C/ebp alpha in cell function and terminal differentiation. Interestingly, C/ebp alpha deficiency did not affect bone formation or monocyte/macrophage development. Our results further demonstrated that C/ebp alpha deficiency suppressed the expression of osteoclast functional genes, e.g. encoding cathepsin K (Ctsk), Atp6i (Tcirg1), and osteoclast regulator genes, e.g. encoding c-fos (Fos), and nuclear factor of activated T-cells 1 (Nfatc1), while having no effect on Pu.1 (Spi1) expression. Promoter activity mapping and ChIP assay defined the critical cis-regulatory element (CCRE) in the promoter region of Nfatc1, and also showed that the CCREs were directly associated with C/ebp alpha, which enhanced the promoter's activity. The deficiency of C/ebp alpha in osteoclasts completely blocked ovariectomy-induced bone loss, indicating that C/ebp alpha is a promising new target for the treatment of osteolytic diseases. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Gs Alpha Controls Cortical Bone Quality By Regulating Osteoclast Differentiation Via Camp/Pka And Beta-Catenin Pathways

Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways

Gα13 Negatively Controls Osteoclastogenesis Through Inhibition of the Akt-GSK3β-NFATc1 Signalling Pathway

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Ablation of Gsα Signaling in Osteoclast Progenitor Cells Adversely Affects Skeletal Bone Maintenance.

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

C/Ebp Alpha Controls Osteoclast Terminal Differentiation, Activation, Function, And Postnatal Bone Homeostasis Through Direct Regulation Of Nfatc1

Regulator of G Protein Signaling Protein 12 (Rgs12) Controls Mouse Osteoblast Differentiation via Calcium Channel/Oscillation and Gαi-ERK Signaling

GNAS knockdown suppresses osteogenic differentiation of mesenchymal stem cells via activation of Hippo signaling pathway

GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells

Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption.

Osteoblastic Molecular Scaffold Gab1 Is Required For Maintaining Bone Homeostasis

G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function

Paternally inherited gsα mutation impairs adipogenesis and potentiates a lean phenotype in vivo.

Loss of BMP Signaling Through BMPR1A in Osteoblasts Leads to Greater Collagen Cross-Link Maturation and Material-Level Mechanical Properties in Mouse Femoral Trabecular Compartments

Notch Signaling in Osteocytes Differentially Regulates Cancellous and Cortical Bone Remodeling

Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program

Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth

Acetyltransferases CBP/p300 control transcriptional switch of β‐catenin and Stat1 promoting osteoblast differentiation